Humulin 7030

Humulin 70/30

<< >>
Usage conditions apply
Description (Brief)
Humulin is human insulin used for treating diabetes. Prior to its development, diabetics used insulin isolated from pig and cow pancreases. Developed by Genentech, the first American biotechnology company, Humulin was licensed to Eli Lilly and became the first marketable product created through recombinant DNA technology. Its licensing by the FDA in October 1982 also made it the first recombinant pharmaceutical approved for use in the United States.
Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human insulin are inserted into bacteria. Bacteria produce insulin, which is harvested and used as the active ingredient in Humulin.
Humulin 70/30 is an intermediate-acting insulin combined with the more rapid onset of action of regular human insulin. The duration of activity may last up to 24 hours following injection.
Object is a sealed white cardboard box with black and red printing.
Currently not on view
Object Name
date made
before 1995
Eli Lilly and Company
place made
United States: Indiana, Indianapolis
Physical Description
human insulin (overall material)
overall: 2 3/4 in x 1 3/8 in x 1 3/8 in; 6.985 cm x 3.4925 cm x 3.4925 cm
overall: 1 5/16 in x 2 7/8 in x 1 5/16 in; 3.33375 cm x 7.3025 cm x 3.33375 cm
ID Number
accession number
catalog number
See more items in
Medicine and Science: Medicine
Health & Medicine
Biotechnology and Genetics
Recombinant Pharmaceuticals
Science & Mathematics
Data Source
National Museum of American History
Nominate this object for photography.   

Our collection database is a work in progress. We may update this record based on further research and review. Learn more about our approach to sharing our collection online.

If you would like to know how you can use content on this page, see the Smithsonian's Terms of Use. If you need to request an image for publication or other use, please visit Rights and Reproductions.

Note: Comment submission is temporarily unavailable while we make improvements to the site. We apologize for the interruption. If you have a question relating to the museum's collections, please first check our Collections FAQ. If you require a personal response, please use our Contact page.